Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial by Jian Wang, Hao Wu, Jing Sun, Xiao Li, Yongqian Shu, Xiaofeng Wu, Guoqiang Wang, Huajun Li, Xiaofeng Chen, Yanhong Gu, Yang Shao, Qianwen Shao, Feipeng Zhu, Xiaofeng Qian, Jun Hu, Fengjiao Zhao, Weidong Mao, Gaohua Han, Changxian Li, Yongxiang Xia, Poshita Kumari Seesaha, Dongqin Zhu, Junling Zhang, Xuehao Wang, Xiangcheng Li

Get full text